Abstract
Malignant phenotype evolves through a fine-tuning of certain inherent molecular programs. Within this context, epigenetic silencing of ADAM23 gene arises as a recurrent event in a wide range of tumors, frequently associated with metastatic disease and/or tumor progression. We show that ADAM23 expression is gradually downregulated during glioma progression compared to normal brain samples,…